The lack of response was associated with a transforming growth factor β (TGF-β) signature in fibroblasts, particularly in patients with CD8+ T cells excluded from the tumor parenchyma and instead found in the fibroblast and collagen-rich peritumoral stroma. This evidence concerns the gene CD8A and neoplasm.